OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
44 hedge funds and large institutions have $112M invested in OptiNose in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 8 closing their positions.
1,220% more call options, than puts
Call options by funds: $330K | Put options by funds: $25K
157% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 7
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
67% more capital invested
Capital invested by funds: $66.9M → $112M (+$45M)
0.14% more ownership
Funds ownership: 3.53% → 3.68% (+0.14%)
0% more funds holding
Funds holding: 44 → 44 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kingdon Capital Management
New York
|
+$4.76M |
| 2 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$4.76M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$952K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$484K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$214K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.18M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.17M |
| 3 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$76K |
| 4 |
N
Natixis
Paris,
France
|
-$57K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$39K |
OPTN Hedge Fund Activity: Q1 2022 in Review
44 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q1 2022, worth a combined $112M — up 67% from $66.9M a quarter earlier.
Fund positioning in OPTN was balanced in Q1 2022: 8 funds opened new positions, 8 closed out, 18 added to existing stakes and 7 trimmed.
The largest buyer was Kingdon Capital Management, opening a new position worth an estimated $4.76M. The largest seller was Stonepine Capital Management, cutting an estimated $2.18M.
- 44 institutional investors held OptiNose (OPTN) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $112M of OptiNose stock for Q1 2022, up 67% quarter-over-quarter.
- 8 funds opened new OptiNose positions in Q1 2022 and 8 closed out, a net change of 0 holders.
- The largest OptiNose buyer in Q1 2022 was Kingdon Capital Management, an estimated $4.76M added.
- The largest OptiNose seller in Q1 2022 was Stonepine Capital Management, an estimated $2.18M sold.
Based on aggregated 13F filings for Q1 2022.